SecBot SecBot
144 ·Filed Jun 11, 2026

AXSM

Axsome Therapeutics, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed5mo ago SEC0001921094-26-000636
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, tax-motivated sale from restricted stock vesting with no trading implications. Monitor for any larger insider dispositions or changes in senior leadership selling patterns, but this filing alone does not warrant a trade action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$255.17
T+0 close · Jun 11, 2026 · via day close
Latest settled
−18.56%
T+60 · $207.82
Vs SPY
−21.82%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $255.17entry
  2. T+1 · 5mo ago −0.69%α −2.46% · $253.40
  3. T+5 · 5mo ago −1.83%α −2.50% · $250.50
  4. T+20 · 4mo ago −8.37%α −10.15% · $233.80
  5. T+60 · 2mo ago −18.56%α −21.82% · $207.82
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome Therapeutics common stock, valued at approximately $70,407. The shares originated from a restricted stock lapse on June 6, 2026, and the sale appears to be a routine tax-withholding transaction. The dollar amount is negligible relative to the company's $12.7B market cap, making this filing inconsequential for traders.

Key Facts

  • Director Roger Jeffs filed Form 144 to sell 286 shares of common stock.
  • Estimated sale value of $70,407 based on June 10, 2026 trade.
  • Shares originated from a restricted stock lapse (equity compensation) on June 6, 2026.
  • Sale constitutes a trivial fraction of the company's $12.7B market capitalization.
  • No indication of a Rule 10b5-1 trading plan (filing marked as 'LIVE'), but size and context suggest routine tax-motivated sale.

Financial Impact

Sale of 286 shares for ~$70,407, representing ~0.0006% of AXSM's market cap.

insider ownership (negligible)

Risk Factors

  • None material, extremely small relative to market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001921094-26-000636
Document: 0001921094-26-000636-index.html0001921094-26-000636
Document: 0001921094-26-000636.txt0001921094-26-000636

Track record

26 reports on AXSM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
  3. Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
  4. Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
  5. Aug 10, 202614w ago 8-K Neutral 6/10 No price data
  6. Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
  7. Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
  8. Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
  10. Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 7h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026